Addex Therapeutics Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Addex Therapeutics Ltd., a foreign private issuer based in Geneva, Switzerland, on August 27, 2020. The filing serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. It acts as a cover document for a press release and does not disclose revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The filing text does not provide details on material changes versus prior periods. The content of the referenced press release (Exhibit 99.1) is not included in the input text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. The filing solely references the existence of a press release without summarizing its contents.
Key Facts for Investor Verification
- Verify the content of the press release dated August 27, 2020, which is attached as Exhibit 99.1 but not included in this summary text.
- Confirm the specific operational or clinical milestone announced in the referenced press release.
- Review the full Form 20-F for the most recent audited financial statements, as this 6-K contains no financial data.